Foundation date



#Medical Technology


SPINOVIT developed an original method to assess the endothelial dysfunction by measuring a biomarker in a 1 mL blood sample. Our solution consists in a patented syringe and measurement of a biomarker by an innovative technology. This biomarker reveals the quantity of nitric oxide (NO) produced by the endothelial cells. As this production is modulated by the risk factors, our biomarker can so provide information on the real risk exposure of a patient allowing so a personalized medicine approach.

This procedure ensures a safe, minimally invasive and cost-effective method for the patient and an easy, reproducible, evidence-based assessment with an incremental value over standard for the physician.

Upcoming events

Latest news

  • Bimekizumab Phase 3 data in hidradenitis suppurativa show clinically meaningful, deep and maintained response over 48 weeks

    Monday March 20th 2023

  • VIB launches Data Core to support life sciences research

    Thursday March 16th 2023

  • Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease

    Thursday March 16th 2023